Sources | Names Used |
---|---|
CTRPv2 | 1S,3R-RSL-3 |
PharmacoGx | 1S,3R-RSL-3 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | C14orf132 | CTRPv2 | pan-cancer | AAC | 0.2 | 4e-07 |
mRNA | GJC1 | CTRPv2 | pan-cancer | AAC | 0.19 | 3e-07 |
mRNA | MEX3A | CTRPv2 | pan-cancer | AAC | 0.18 | 7e-06 |
mRNA | SCRN1 | CTRPv2 | pan-cancer | AAC | 0.18 | 9e-07 |
mRNA | ATP6V1G2 | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-06 |
mRNA | TMEFF1 | CTRPv2 | pan-cancer | AAC | 0.17 | 3e-05 |
mRNA | MSANTD3-TMEFF1 | CTRPv2 | pan-cancer | AAC | 0.17 | 4e-05 |
mRNA | CCDC177 | CTRPv2 | pan-cancer | AAC | 0.17 | 4e-07 |
mRNA | RCOR2 | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-06 |
mRNA | C11orf95 | CTRPv2 | pan-cancer | AAC | 0.17 | 3e-06 |